GLG News by Reimbursement Experts of PBM Services in Disease Management

This drug will allow patients in severe pain to get the necessary pain relief and not have to worry about the other patients that abuse the drug.

It is important to understand the generic implications when it comes to drug product olacement on the formulary.

This article is informative because it draws conclusions about Zyprexa.

    Physicians have been prescribing lower dose Cialis...off label... for a long time. The FDA finally agreed and approved it.

Exubera is a great product. However, the delivery system was difficult to use and educate the patients how to use. Hopefully, the next generation of the product will be in a smaller more user friendly cannister.

I know that Pfizer finally came out with the inhaled insulin after many years of hype. Unfortunately its launch and the product has been a flop, primarily because of the size if the inhaler. It is large and looks like a can of tennis balls. It is difficult for the patient to understand the dosing and...

I disagree with the Reuters article. Tamiflu is a safe and effective drug for the young and elderly population.

Soma has been around for many years. Now we have a new strength? Probably because there is no generic available on the 250mg.

    Both of Dr. Steven Nissen’s publications are meta-analysis, implying a weakness in their sampling.  In my opinion, more refined studies with larger sample sizes and standardized measurements with Actos, Avandia and placebo or other medications need to be evaluated. ...

Patients may have little understanding of a particular disease state or how to treat it, but with TV advertising they are asking their physicians to prescribe a particular advertised product which is usually quite expensive. There are usually comparable treatments available at a lower cost.